Obesity clinical trials
Showing 301–350 of 714 active trials. Describe your situation to see which ones you may be eligible for.
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
- Preventing Type 2 Diabetes in Black Emergent Adult
- A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Mechanisms Underlying Individual Variations of Taste and Smell in Obesity
- Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care
- Improving Sleep, Decision-Making, and Eating in Adolescents With Obesity
- Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
- A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
- Low Gas Pressure vs Standard Gas Pressure in Weight-Loss Surgery
- Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise
- The Metabolic and Genetic Drivers of Body Composition Changes Following Weight Loss Surgery
- A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- The Effects of Strength Training on Muscle Mass and Mental Health in Adults Taking Obesity Medication
- PRImary Care Strategies for Weight Management (PRISM) Study
- Brief Inhibitory Training for Eating - Intervention
- Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
- Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer
- A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Weight Loss in Adults Using Semaglutide (Real-world Study)
- Body Composition Outcomes in MS Patients
- GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
- People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
- Healthy Living BEYOND Weight Study
- Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- MagDI U.S. Registry
- Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
- Pennington Generation Cohort
- Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
- Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults
- Brain Blood Flow and Lactate in Non-obese and Obese Subjects
- Study of Patients Being Treated With Anti-obesity Medication
- Intensive Longitudinal Assessment of Stress and Stress-related Concepts Across a Behavioral Weight Loss Intervention
- Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
- Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes
- Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.
- Fundus Ablation Registry (Gastric Fundus Mucosal Ablation for Weight Loss)
- Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)
- Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)
- Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
- The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology
- The Weight of Cardiovascular Disease
- Exercise Response in Humans With Obesity
- Genetic Disorders of Obesity Program Database
- Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.